

Stamping out high-risk myeloma with D-KRd and tandem transplant; plasmin-cleaved VWF in microthrombosis; SCD plasma sensitizes iPSC-derived sensory neurons
4 snips May 16, 2024
This podcast explores stamping out high-risk myeloma with innovative treatments, plasmin-cleaved VWF in microthrombosis, and new insights into sickle cell pain mechanisms. Topics include tandem transplant for myeloma, CVWF as a biomarker for thrombotic diseases, and sensitization of SCD patient-derived sensory neurons.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Improving Survival in Myeloma Patients with High-Risk Cytogenetics through Tandem Transplant
03:07 • 2min
Exploring Treatment Approaches for High-Risk Myeloma and Response Durability
05:03 • 4min
CVWF as a Biomarker in TTP and Neurobiological Mechanisms of Pain in SCD Patients
08:56 • 6min
Exploring Sensitization in Sickle Cell Disease Pain
14:50 • 5min